Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

por Harada, H, Itasaka, S, Zhu, Y, Zeng, L, Xie, X, Morinibu, A, Shinomiya, K, Hiraoka, M
Publicado 2009

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

por Nakamura, T., Ito, M., Hashimoto, J., Shinomiya, K., Asao, Y., Katsumata, K., Hagino, H., Inoue, T., Nakano, T., Mizunuma, H.
Publicado 2015

Involvement of decreased hypoxia-inducible factor 1 activity and resultant G(1)–S cell cycle transition in radioresistance of perinecrotic tumor cells

por Zhu, Y, Zhao, T, Itasaka, S, Zeng, L, Yeom, C J, Hirota, K, Suzuki, K, Morinibu, A, Shinomiya, K, Ou, G, Yoshimura, M, Hiraoka, M, Harada, H
Publicado 2013

Trends in incidence and mortality of tuberculosis in Japan: a population-based study, 1997–2016

por Hagiya, H., Koyama, T., Zamami, Y., Minato, Y., Tatebe, Y., Mikami, N., Teratani, Y., Ohshima, A., Shinomiya, K., Kitamura, Y., Sendo, T., Hinotsu, S., Tomono, K., Kano, M. R.
Publicado 2018

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION

por Röth, A., Egyed, M., Ichikawa, S., Ito, Y., Kim, J. S., Nagy, Z., Obara, N., Panse, J., Schrezenmeier, H., Sica, S., Soret, J., Usuki, K., Yoon, S.-S., Benkali, K., Buri, M., Lundberg, P., Patel, H., Shinomiya, K., Sreckovic, S., Nishimura, J.-I.
Publicado 2022